Young Jonathan (CIK 1779805) reported 29 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-09). Recent activity: Sell AKRO (152,616 shares), Sell AKRO (20,000 shares), Sell AKRO (20,000 shares), Sell AKRO (20,000 shares), Sell AKRO (47,573 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 152,616 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 20,000 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 20,000 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 20,000 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 47,573 | $0 |
| 2025-11-26 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Buy | 4,284 | $90,350 |
| 2025-11-26 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Buy | 3,527 | $99,990 |
| 2025-11-26 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Buy | 4,739 | $99,993 |
| 2025-11-26 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 9,259 | $0 |
| 2025-10-03 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Buy | 12,500 | $263,750 |
| 2025-10-03 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 8,299 | $395,364 |
| 2025-10-03 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 4,201 | $201,564 |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 586 | $25,210 |
| 2025-09-04 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Buy | 12,500 | $263,750 |
| 2025-09-04 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 9,700 | $444,066 |
| 2025-09-04 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 2,739 | $129,116 |
| 2025-09-04 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 61 | $2,902 |
| 2025-08-13 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Buy | 12,500 | $263,750 |
| 2025-08-13 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 11,151 | $532,126 |
| 2025-08-13 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 1,349 | $65,184 |
| 2025-07-02 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Buy | 890 | $21,244 |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 1,453 | $79,683 |
| 2025-06-12 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 2,493 | $134,597 |
| 2025-03-14 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 607 | $27,242 |
| 2025-03-05 | Akero Therapeutics, Inc. (AKRO) | Chief Operating Officer | Sell | 11,447 | $505,614 |
Source: SEC Form 4 filings · as of 2025-12-09